Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Germline assessment for alloHSCT candidates over 50 years: A 'Fast-Track' screening in myeloid neoplasms.
Torres-Esquius S, Beas F, Chen-Liang TH, Pomares H, Santiago M, Varela ND, Liquori A, Hernandez F, Xicoy B, Hermosín L, Arnan M, Tazón-Vega B, Blanco A, Cervera J, Diez-Campelo M, Lozano ML, Valcárcel D, Bosch F, Montoro MJ, Jerez A; GESMD centres. Torres-Esquius S, et al. Among authors: lozano ml. Br J Haematol. 2024 Aug;205(2):503-509. doi: 10.1111/bjh.19460. Epub 2024 Apr 19. Br J Haematol. 2024. PMID: 38639421
Thrombotic risk and features of patients with inferior vena cava agenesis: a multicentre, retrospective, observational study.
Bravo-Pérez C, Blanco A, Revilla N, Cobos J, Salgado-Parente A, Asenjo S, Méndez R, Marti-Bonmati L, Bonanad S, Albillos JC, Castro N, Marcellini S, López Sala P, Lasa M, Bastida JM, Infante MS, Corral MA, Pagan J, Llamas P, Rodríguez-Sevilla JJ, Rodríguez-Alen A, Sevivas TS, Morello D, Villar CG, Lojo S, Marco A, Simioni P, Vicente V, Lozano ML, de la Morena-Barrio ME, García-Santos JM, Corral J; IVC Agenesis Study Group. Bravo-Pérez C, et al. Among authors: lozano ml. Lancet Haematol. 2024 Aug;11(8):e606-e616. doi: 10.1016/S2352-3026(24)00138-8. Epub 2024 Jun 12. Lancet Haematol. 2024. PMID: 38878784
Recommendations for the future management of thrombocytopenia in patients with liver cirrhosis: A modified RAND/UCLA appropriateness method.
Calleja JL, Delgado Sánchez O, Fuentes Pradera MÁ, Llop E, López Zárraga F, Lozano ML, Parra R, Turnes J. Calleja JL, et al. Among authors: lozano ml. Gastroenterol Hepatol. 2024 Jan;47(1):32-50. doi: 10.1016/j.gastrohep.2023.03.008. Epub 2023 Apr 5. Gastroenterol Hepatol. 2024. PMID: 37028757 English, Spanish.
Analysis of AlphaFold and molecular dynamics structure predictions of mutations in serpins.
Garrido-Rodríguez P, Carmena-Bargueño M, de la Morena-Barrio ME, Bravo-Pérez C, de la Morena-Barrio B, Cifuentes-Riquelme R, Lozano ML, Pérez-Sánchez H, Corral J. Garrido-Rodríguez P, et al. Among authors: lozano ml. PLoS One. 2024 Jul 5;19(7):e0304451. doi: 10.1371/journal.pone.0304451. eCollection 2024. PLoS One. 2024. PMID: 38968282 Free PMC article.
Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice.
González-López TJ, Bermejo-Vega N, Cardesa-Cabrera R, Martínez-Robles V, Aguilar-Monserrate G, Pérez-Segura G, Domingo A, Luis-Navarro J, Lakhwani S, Acedo N, Lozano ML, Bernat S, Torres-Tienza A, Ruano A, Jarque I, Galán P, Benet C, Marcellini S, Jimenez-Bárcenas R, Martínez-Carballeira D, De Miguel-Llorente D, Perona-Blázquez A, Gonzalez-Gascón I, Lopez-Ansoar E, Alonso-Alonso JM, Bengochea-Casado ML, Díaz-Gálvez FJ, Moretó A, Moreno-Jiménez G, Hernández-Martin R, de Cabo E, Dávila-Valls J, Cuesta A, Pastoriza C, Hermida-Fernández GJ, García C, Pozas-Mañas MA, Aguilar C, Fernandez-Jimenez D, Navas-Elorza B, López-Santamaría Castro C, Lorenzo A, Ortín X, García M, Piernas S, Díaz-Santa J, Soto I, Provan D, García-Donas Gabaldón G. González-López TJ, et al. Among authors: lozano ml. Blood. 2024 Aug 8;144(6):646-656. doi: 10.1182/blood.2024024250. Blood. 2024. PMID: 38843478
The whole is greater than the sum of its parts: Long-read sequencing for solving clinical problems in haematology.
Bravo-Perez C, Cifuentes-Riquelme R, Padilla J, de la Morena-Barrio ME, Ortuño FJ, Garrido-Rodríguez P, Amigo ML, Heras I, Vicente V, Lozano ML, Teruel-Montoya R, de la Morena-Barrio B, Corral J. Bravo-Perez C, et al. Among authors: lozano ml. J Cell Mol Med. 2024 Feb;28(3):e17961. doi: 10.1111/jcmm.17961. Epub 2024 Jan 23. J Cell Mol Med. 2024. PMID: 38260950 Free PMC article. No abstract available.
NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy.
Hurtado-Navarro L, Cuenca-Zamora EJ, Zamora L, Bellosillo B, Such E, Soler-Espejo E, Martínez-Banaclocha H, Hernández-Rivas JM, Marco-Ayala J, Martínez-Alarcón L, Linares-Latorre L, García-Ávila S, Amat-Martínez P, González T, Arnan M, Pomares-Marín H, Carreño-Tarragona G, Chen-Liang TH, Herranz MT, García-Palenciano C, Morales ML, Jerez A, Lozano ML, Teruel-Montoya R, Pelegrín P, Ferrer-Marín F. Hurtado-Navarro L, et al. Among authors: lozano ml. Cell Rep Med. 2023 Dec 19;4(12):101329. doi: 10.1016/j.xcrm.2023.101329. Cell Rep Med. 2023. PMID: 38118408 Free PMC article.
180 results